Four Approaches to AI in Regulatory Publishing

The AI regulatory publishing landscape is dividing into four distinct approaches, each with genuine strengths and real limitations. This article attempts an honest assessment of all four — including the one we’re building.

We’re a vendor in this space, so we have a perspective. We’ve tried to be fair. Where we don’t know a competitor’s internal details, we say so rather than guessing.

Approach 1: Legacy RIM Vendors (Veeva, IQVIA)

Strengths

  • Massive installed base. Veeva RIM is used by most of the top 20 pharma companies. When a regulatory authority changes a requirement, Veeva has direct relationships to understand and implement it.
  • Deep regulatory domain data. Decades of submission data, agency interaction patterns, and regulatory intelligence built into their platforms.
  • Proven enterprise track record. Hundreds of enterprise customers, validated environments, established support infrastructure.
  • Ecosystem effects. Veeva Vault connects RIM to CTMS, QMS, and safety — a single-vendor story that reduces integration complexity.

AI Approach

Adding AI capabilities to existing platforms: copilots for document drafting, assistants for regulatory intelligence queries, predictive analytics on submission timelines. The AI features extend the existing product rather than redesigning it.

Limitations

  • Architectural constraints. Platforms designed in the 2010s around database-centric architectures. AI is additive, not structural — audit trails for AI actions may require retrofitting.
  • Closed ecosystems. Limited ability for customers to bring their own AI models or integrate external AI agents.
  • Cost. Enterprise pricing models that can run to six or seven figures annually, with significant professional services costs for customization.

Fair acknowledgment: Veeva’s data advantage is real and difficult to replicate. A smaller vendor with better architecture but less data may not deliver better outcomes.

Approach 2: Kivo (Headless GxP)

Strengths

  • Clean architecture. Designed for AI integration from inception, using MCP as the primary interaction protocol.
  • Simple integration pitch. “Plug your existing AI agent into our compliance API” is easier to adopt than “replace your regulatory platform.”
  • Agent-agnostic. Works with any AI provider — no vendor lock-in on the AI side.
  • Clear interaction pattern. “AI researches and recommends, human acts, system records both” is intuitive and auditor-friendly.

AI Approach

Compliance-as-an-API. The GxP compliance engine is exposed via MCP, allowing external AI agents to interact with compliance records while the system enforces access controls and audit logging.

Limitations

  • Early stage. Three features announced for private beta in July 2026. Limited public information about the depth of the compliance infrastructure behind the API.
  • Scope. Based on available information, focused on compliance record-keeping rather than full regulatory publishing (eCTD assembly, validation, multi-region submission).
  • Market presence. Newer company with fewer published case studies or enterprise references.

Fair acknowledgment: We don’t have full visibility into Kivo’s product. Their actual capabilities may be broader than what’s publicly visible. We’re comparing based on public announcements.

Approach 3: DnXT (Open GxP)

Strengths

  • Full regulatory platform in production. eCTD publishing, validation (23 PDF compliance rules), document management, workflow engine (50+ endpoints), multi-region support (US, EU, JP, CA, AU).
  • AI-native infrastructure. Audit trails built into the data write layer, 4-layer tenant isolation, e-signature service designed for Part 11, MCP tools in production use since March 2026.
  • Compliance enforcement. Hard technical blocks on AI agent actions (cannot sign, cannot publish, cannot access other tenants).
  • Existing MCP experience. 30 internal tools across 3 servers, with established guardrail patterns.

AI Approach

AI-native platform where compliance is structural. Planning to expose existing REST endpoints via a customer-facing MCP server with OAuth2, tenant scoping, and permission enforcement.

Limitations

  • Small company. DnXT is a startup-scale team competing against companies with thousands of employees and hundreds of enterprise customers.
  • Fewer enterprise references. Limited published case studies compared to Veeva or IQVIA. A prospective customer has less third-party validation to rely on.
  • Customer-facing MCP server is not live yet. The internal tools and REST API are in production, but the customer-facing gateway is in design.
  • Custom workflow engine. Built in-house rather than using established engines (Camunda, Temporal) — more control but more maintenance risk for a small team.

Fair acknowledgment: DnXT’s architectural advantages are real, but architecture doesn’t close deals — customer references, enterprise support, and market trust do. We’re earlier in that journey than our competitors.

Approach 4: Generic AI (Claude, GPT, Gemini Directly)

Strengths

  • Powerful general-purpose AI. Capable of drafting regulatory documents, analyzing submission data, answering regulatory questions.
  • No vendor lock-in. Use any model for any task.
  • Low cost. API pricing is a fraction of enterprise regulatory platform subscriptions.
  • Flexibility. Can be integrated into any workflow or tool chain.

Limitations

  • No regulatory domain enforcement. A general AI model doesn’t know that a 505(b)(2) submission requires different eCTD sections than an ANDA. It can learn from context, but it doesn’t enforce.
  • No compliance infrastructure. No audit trails, no e-signatures, no tenant isolation, no validation rules.
  • No accountability framework. When a generic AI makes an error in a regulatory context, there’s no built-in remediation process.

Fair acknowledgment: For ad-hoc research, drafting, and analysis, generic AI is genuinely useful and cost-effective. Not every regulatory task requires a full compliance platform.

Comparison Matrix

Based on publicly available information as of May 2026:

Capability Veeva/IQVIA Kivo DnXT Generic AI
MCP Support Not announced Yes (beta July) Yes (internal prod, customer planned) Varies
21 CFR Part 11 Audit Trail Yes (established) Announced Yes (structural, ALCOA+) No
E-Signatures Yes Unknown Yes (Part 11 compliant) No
Tenant Isolation Yes Announced Yes (4-layer architectural) No
eCTD Publishing Yes (market leader) Not announced Yes (multi-region) No
Validation Engine Yes Not announced Yes (23 rules, multi-region) No
Enterprise References Hundreds Early stage Growing N/A
AI Provider Flexibility Limited Any (MCP) Any (MCP, planned) Any

The right choice depends on where your organization is today: established Veeva customers adding AI, companies wanting a compliance API layer (Kivo), organizations ready for an AI-native platform (DnXT), or teams using AI for ad-hoc regulatory work (generic AI). There is no universal best answer.

This article was written by the DnXT Solutions team. We’ve made every effort to represent competitors fairly based on public information. If we’ve gotten something wrong, we welcome corrections at se******@***********ns.com.